Accelerating the Implementation of a Breast and Cervical Cancer Screening and HPV Vaccination Intervention for Under-served Hispanics
Accelerating the Implementation of a Breast and Cervical Cancer Screening and HPV Vaccination Intervention for Under-served Hispanics
The proposed study will develop and test an implementation strategy called Salud en Mis Manos-Dissemination and Implementation Assistance (SEMM-DIA) which is an internet-accessible cross-platform that includes additional implementation support strategies to increase the reach, effectiveness, and implementation of an evidence-based breast and cervical cancer screening and HPV vaccination program for Latinas (SEMM).
This study tests a multicomponent and multifaceted implementation strategy, SEMM-DIA and serves as a model for developing other implementation strategies designed to build the capacity of clinic leadership, intervention champions, and LHWs to plan, manage, and deliver SEMM. Investigators will examine the effect of SEMM-DIA program implementation in a randomized group trial comparing the impact of SEMM-DIA vs. SEMM- Usual Implementation Practice on the reach, effectiveness, implementation, and cost-effectiveness of SEMM in safety-net clinics.
Inclusion Criteria:
Organization inclusion criteria:
SEMM Participant Inclusion criteria:
Latinas who self-identify as Hispanic/Latina.
Latinas who have at least one unmet breast or cervical cancer prevention need, following Electronic Clinical Quality Measures.
(1) Latinas aged 21-64 years who have not had a Pap test in the past 3 years, and (2) Latinas aged 30-64 who have not had a HPV test in the past 5 years (CMS eCQM ID: CMS124v9).
(3) Latinas aged 51-74 years who have not had a mammogram in the past 2 years (CMS eCQM ID: CMS125v9).
(4) Latinas aged 18-26 years who have not initiated HPV vaccination.
Exclusion Criteria:
Organization exclusion criteria:
- Clinics/Community Health Centers not located in Texas.
SEMM Participant Exclusion criteria:
- Latinas with a prior or current cancer diagnosis due to modified cancer screening surveillance guidelines for cancer survivors.